These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9546516)

  • 1. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease.
    Ballard C; Grace J; McKeith I; Holmes C
    Lancet; 1998 Apr; 351(9108):1032-3. PubMed ID: 9546516
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinguishing Lewy body dementia.
    Lapalio LR; Sakla SS
    Hosp Pract (1995); 1998 Feb; 33(2):93-6, 99-102, 107-8. PubMed ID: 9484298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.
    Aarsland D; Perry R; Larsen JP; McKeith IG; O'Brien JT; Perry EK; Burn D; Ballard CG
    J Clin Psychiatry; 2005 May; 66(5):633-7. PubMed ID: 15889951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease and Lewy body dementia.
    Levy R
    Br J Psychiatry; 1994 Feb; 164(2):268. PubMed ID: 8173836
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic sensitivity to risperidone in Lewy body dementia.
    McKeith IG; Ballard CG; Harrison RW
    Lancet; 1995 Sep; 346(8976):699. PubMed ID: 7544860
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dementia in Parkinson disease: Lewy body disease or Alzheimer's disease?].
    Jansen EN; de Vos RA
    Ned Tijdschr Geneeskd; 1994 Jun; 138(26):1305-9. PubMed ID: 8028672
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
    Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic sensitivity in dementia with cortical Lewy bodies.
    Byrne EJ; Burns A; Waite J
    BMJ; 1992 Nov; 305(6862):1158-9. PubMed ID: 1361158
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic sensitivity in patients with senile dementia of Lewy body type.
    McKeith I; Fairbairn A; Perry R; Thompson P; Perry E
    BMJ; 1992 Sep; 305(6855):673-8. PubMed ID: 1356550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse Lewy body disease: a common yet misdiagnosed dementia in which neuroleptics may be contraindicated.
    Scarbrough TJ
    Tenn Med; 1998 Feb; 91(2):58-60. PubMed ID: 9478123
    [No Abstract]   [Full Text] [Related]  

  • 11. Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study.
    Ala TA; Yang KH; Sung JH; Frey WH
    J Neurol Neurosurg Psychiatry; 1997 Jan; 62(1):16-21. PubMed ID: 9010394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dementia with Lewy bodies.
    Kosaka K; Iseki E
    Curr Opin Neurol; 1996 Aug; 9(4):271-5. PubMed ID: 8858184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dementia with Lewy bodies. Pure and mixed forms].
    del Ser T
    Rev Neurol; 2002 Oct 16-31; 35(8):761-5. PubMed ID: 12402230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome following quetiapine treatment in a patient with dementia with Lewy bodies.
    Kobayashi R; Matsumoto Y; Hayashi H; Suzuki A; Otani K
    Asian J Psychiatr; 2017 Dec; 30():173-174. PubMed ID: 29080512
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dementia: Where are the Lewy bodies?].
    Lebouvier T; Delrieu J; Evain S; Pallardy A; Sauvaget A; Letournel F; Chevrier R; Lepetit M; Vercelletto M; Boutoleau-Bretonnière C; Derkinderen P
    Rev Neurol (Paris); 2013 Nov; 169(11):844-57. PubMed ID: 24103321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical features of Parkinson's disease in 100 histologically proven cases.
    Hughes AJ; Daniel SE; Lees AJ
    Adv Neurol; 1993; 60():595-9. PubMed ID: 8420197
    [No Abstract]   [Full Text] [Related]  

  • 18. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
    McShane RH; Nagy Z; Esiri MM; King E; Joachim C; Sullivan N; Smith AD
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):739-43. PubMed ID: 11385006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making the diagnosis of mixed and non-Alzheimer's dementias.
    Hansen LA; Crain BJ
    Arch Pathol Lab Med; 1995 Nov; 119(11):1023-31. PubMed ID: 7487402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine and neuroleptic malignant syndrome.
    Tofler I
    Psychosomatics; 2002; 43(6):505-6; author reply 506. PubMed ID: 12444237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.